Erik Tambuyzer
Director/Miembro de la Junta en Augustine Therapeutics NV .
Cargos activos de Erik Tambuyzer
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Augustine Therapeutics NV
 Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Augustine Therapeutics NV is a Belgian company that focuses on developing innovative therapies for neuromuscular and neurodegenerative diseases. The company is based in Leuven, Belgium. The company's main focus is on HDAC6, a class II histone deacetylase, which is a well-known molecular target in various diseases, particularly neurodegenerative disorders and neuropathies. The company was founded in 2019, and Sylvain Celanire has been the CEO of the company since 2020. | Director/Miembro de la Junta | 19/03/2021 | - |
Historial de carrera de Erik Tambuyzer
Formación de Erik Tambuyzer.
| Katholieke Universiteit Leuven | Doctorate Degree |
Estadísticas
Internacional
| Bélgica | 3 |
Operativa
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Services | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Augustine Therapeutics NV
Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Augustine Therapeutics NV is a Belgian company that focuses on developing innovative therapies for neuromuscular and neurodegenerative diseases. The company is based in Leuven, Belgium. The company's main focus is on HDAC6, a class II histone deacetylase, which is a well-known molecular target in various diseases, particularly neurodegenerative disorders and neuropathies. The company was founded in 2019, and Sylvain Celanire has been the CEO of the company since 2020. | Health Services |
- Bolsa de valores
- Insiders
- Erik Tambuyzer
- Experiencia
